Quick Summary of Abbvie GK Japan ver.2015

SKU:

$100.00

Unavailable

per item

This report is good for a company/person who want to quickly learn about keys for this company.

Company Overview
Financial Summary
Main Therapeutic Area
Key Products
Pipeline
Organization (if any)
Strategy
Update (if any)

Quantity

Add to Cart

AbbVie GK operates as a Japanese subsidiary of AbbVie Inc. The biopharmaceutical company that was spun off from Abbott Japan, has officially begun its operations on January 1, 2013. Its main therapeutic areas are immunology, oncology, CNS, women’s health, and renal disease.